LLNL and neurotechnology company Canaery have developed an advanced nose-computer interface (NCI) capable of enhancing the ability of scent-detection animals to simultaneously identify contraband such as explosives and narcotics, as well as other types of important scents such as biomarkers for neurological and infectious diseases.
Nanofabrication of the implantable device is led by staff research engineer Travis Massey in LLNL’s Implantable Microsystems Group, and initially began under a Cooperative Research and Development Agreement (CRADA) through LLNL’s Innovation and Partnership’s Office (IPO). The work is now part of a strategic partnership between LLNL and Canaery.
Technology Portfolio
